Filing Details
- Accession Number:
- 0000939767-17-000075
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-05 18:53:05
- Reporting Period:
- 2017-05-03
- Filing Date:
- 2017-05-05
- Accepted Time:
- 2017-05-05 18:53:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
939767 | Exelixis Inc. | EXEL | Services-Commercial Physical & Biological Research (8731) | 043257395 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1202096 | Michael Morrissey | C/O Exelixis, Inc. 210 E. Grand Ave. South San Francisco CA 94080 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-05-03 | 69,427 | $1.90 | 129,427 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-05-03 | 69,427 | $22.72 | 60,000 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-05-03 | 30,573 | $1.90 | 90,573 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-05-03 | 30,573 | $22.55 | 60,000 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-05-04 | 59,149 | $1.90 | 119,149 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-05-04 | 59,149 | $22.17 | 60,000 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-05-05 | 89,555 | $1.90 | 149,555 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-05-05 | 89,555 | $21.87 | 60,000 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-05-05 | 10,445 | $1.90 | 70,445 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-05-05 | 10,445 | $21.65 | 60,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option (right to buy) | Disposition | 2017-05-03 | 69,427 | $0.00 | 69,427 | $1.90 |
Common Stock | Option (right to buy) | Disposition | 2017-05-03 | 30,573 | $0.00 | 30,573 | $1.90 |
Common Stock | Option (right to buy) | Disposition | 2017-05-04 | 59,149 | $0.00 | 59,149 | $1.90 |
Common Stock | Option (right to buy) | Disposition | 2017-05-05 | 89,555 | $0.00 | 89,555 | $1.90 |
Common Stock | Option (right to buy) | Disposition | 2017-05-05 | 10,445 | $0.00 | 10,445 | $1.90 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
380,573 | 2015-07-20 | 2022-02-04 | No | 4 | M | Direct |
350,000 | 2015-07-20 | 2022-02-04 | No | 4 | M | Direct |
290,851 | 2015-07-20 | 2022-02-04 | No | 4 | M | Direct |
201,296 | 2015-07-20 | 2022-02-04 | No | 4 | M | Direct |
190,851 | 2015-07-20 | 2022-02-04 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 172,698 | Indirect | By Trust |
Common Stock | 16,970 | Indirect | By 401(k) |
Footnotes
- Includes 60,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.70 to $22.79. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
- Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.15 to $22.20. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
- Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.85 to $21.93. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.
- Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.65 to $21.66. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 5 to this Form 4.
- Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.
- Represents 16,970 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 2, 2017.
- The option, representing the right to purchase a total of 450,000 shares of Exelixis, Inc. common stock, became exercisable as to fifty percent (50%) of the shares subject to the option on July 20, 2015, as to twenty-five (25%) of the shares subject to the option on March 7, 2016 and as to the remaining twenty-five (25%) of the shares subject to the option on April 28, 2016.